Breast cancer survivors must remain vigilant for recurrence signs, which can manifest locally, regionally, or distantly. New ...
FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical company pioneering SYNC-T, an in situ personalized combination ...
The phase 2 ChonDRAgon study compared ozekibart to placebo in patients with metastatic or unresectable conventional chondrosarcoma who been diagnosed with radiographic progression.
Osvyrti and Jubereq are FDA-approved denosumab biosimilars for osteoporosis and cancer-related skeletal events, ...
Dervis, A. (2025) Curative Outcome of Osteosarcoma with Associated Pleural Effusion: A Case Report —Bone Tumor with Pleural ...
Aspirin is another common anti-inflammatory medicine, and omega-3s are nutrients found in fish and nuts that are good for the ...
– Breast surgery seems to help control cancer in the breast. It could also improve life expectancy for some women.
This study presents a case report on pain management and comfort care practices for a 52-year-old male patient with advanced osteosarcoma recurrence and systemic metastasis. The patient presented with ...
HER back pain was so debilitating she couldn’t sleep and had to crawl to the bathroom. Even more frighteningly, she was ...
Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology ...
Symptoms like feeling a breast lump, urinary tract symptoms, a change in bowel habits or a chronic cough, can signal underlying cancers, that should prompt you to seek evaluation by a doctor — an onco ...
The FDA has granted an accelerated approval to sevabertinib (Hyrnuo) for the treatment of adult patients with previously ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果